UBS O'Connor’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
21,409
-1,151
| -5% | -$58.6K | 0.06% | 185 |
|
|
2025
Q1 | $1.02M | Sell |
22,560
-2,499
| -10% | -$113K | 0.03% | 172 |
|
|
2024
Q4 | $1.04M | Buy |
25,059
+8,521
| +52% | +$352K | 0.03% | 218 |
|
|
2024
Q3 | $645K | Sell |
16,538
-21,550
| -57% | -$840K | 0.02% | 318 |
|
|
2024
Q2 | $1.3M | Sell |
38,088
-11,769
| -24% | -$402K | 0.04% | 256 |
|
|
2024
Q1 | $1.25M | Sell |
49,857
-55
| -0.1% | -$1.38K | 0.04% | 251 |
|
|
2023
Q4 | $1.47M | Sell |
49,912
-11,088
| -18% | -$327K | 0.05% | 217 |
|
|
2023
Q3 | $1.93M | Buy |
61,000
+37,000
| +154% | +$1.17M | 0.03% | 248 |
|
|
2023
Q2 | $621K | Buy |
+24,000
| New | +$621K | 0.01% | 420 |
|